 |
Articles: Demyelinating Disorders |
Prior Articles
Cost Effectiveness of Glatiramer Acetate and Natalizumab in Relapsing-Remitting Multiple Sclerosis
Applied Health Economics and Health Policy, 09/18/09
Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis
Journal of Neuroimmunology, 09/18/09 Randomized sequential trial of valproic acid in amyotrophic lateral sclerosis
Annals of Neurology, 09/17/09 Insight in ALS: Awareness of behavioral change in patients with and without FTD
Amyotrophic Lateral Sclerosis, 09/16/09 Pathogenic CD8+ T cells in multiple sclerosis
Annals of Neurology, 09/16/09 Physical and Cognitive Functioning After 3 Years Can Be Predicted Using Information From the Diagnostic Process in Recently Diagnosed Multiple Sclerosis
Archives of Physical Medicine and Rehabilitation, 09/15/09 Effect of immigration on multiple sclerosis sex ratio in Canada: the Canadian Collaborative Study
Journal of Neurology, Neurosurgery, and Psychiatry, 09/15/09 Notch: A new player in MS mechanisms
Journal of Neuroimmunology, 09/15/09 Small but powerful: Short peptide hormones and their role in autoimmune inflammation
Journal of Neuroimmunology, 09/15/09 Incidence of amyotrophic lateral sclerosis in Europe
Journal of Neurology, Neurosurgery, and Psychiatry, 09/15/09 Cancer in patients with motor neuron disease, multiple sclerosis, and Parkinson’s disease: record-linkage studies
Journal of Neurology, Neurosurgery, and Psychiatry, 09/14/09 Longitudinally Extensive Myelopathy in Caucasians: A West Australian Study of 26 cases from the Perth Demyelinating Diseases Database
Journal of Neurology, Neurosurgery, and Psychiatry, 09/14/09 Treatment of early multiple sclerosis: the value of treatment initiation after a first clinical episode
Multiple Sclerosis, 09/11/09 The functional index for living with multiple sclerosis: development and validation of a new quality of life questionnaire
Multiple Sclerosis, 09/11/09 250 mug or 500 mug interferon beta-1b versus 20 mg glatiramer acetate in relapsing-remitting multiple sclerosis: a prospective, randomised, multicentre study
The Lancet Neurology, 09/10/09 CTLA4 exon 1 and promoter polymorphisms in patients with multiple sclerosis
Acta Neurologica Scandinavica, 09/10/09 Fatigue Is Not Associated with Impaired Function of Regulatory T Cells in Untreated Patients with Multiple Sclerosis
European Neurology, 09/10/09 Analysis of FUS gene mutation in familial amyotrophic lateral sclerosis within an Italian cohort
Neurology, 09/10/09 Mutations in FUS cause FALS and SALS in French and French Canadian populations
Neurology, 09/10/09 Anomalous venous blood flow and iron deposition in multiple sclerosis
Journal of Cerebral Blood Flow & Metabolism, 09/09/09
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Current Opinion in Neurology, Stroke, Seizure, Cephalgia, Brain Injury
more...
|
250 Available Pages
|
|
